Clinical Trial Update: Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating intrathecal baclofen therapy for therapy-resistant spasticity in cerebral palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Cerebral Palsy | Phase 2 | Status: COMPLETED